FIELD: medicine, pharmaceutics.
SUBSTANCE: what is offered is using 40-O-(2-hydroxyethyl)rapamycin for preparing a pharmaceutical composition for treating a renal tumour representing carcinoma.
EFFECT: 40-O-(2-hydroxyethyl)rapamycin twice reduces tumour growth time or death rate of the patients with advanced renal cell carcinoma.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF RAPAMYCIN DERIVATIVE | 2011 |
|
RU2483727C1 |
| APPLICATION OF RAPAMYCIN DERIVATIVE | 2013 |
|
RU2659725C2 |
| APPLICATION OF RAPAMYCIN DERIVATIVE | 2013 |
|
RU2665138C2 |
| CANCER MEDICAL TREATMENT | 2005 |
|
RU2325906C2 |
| COMBINATION AND METHOD FOR PROPHYLAXIS OF BREAST CANCER | 2002 |
|
RU2322981C2 |
| RAPAMYCIN DERIVATIVE OR IMPDH INHIBITOR FOR TREATING POLYCYSTIC KIDNEY DISEASE | 2006 |
|
RU2491933C2 |
| NANOPARTICLE, CONTAINING RAPAMYCIN AND ALBUMIN AS ANTICANCER AGENT | 2013 |
|
RU2678448C2 |
| NANOPARTICLE, CONTAINING RAPAMYCIN AND ALBUMIN AS ANTI-CANCER AGENT | 2008 |
|
RU2483714C2 |
| BIOMARKERS | 2005 |
|
RU2429297C2 |
| BIOMARKER | 2005 |
|
RU2385944C2 |
